UniProt ID | DGKA_HUMAN | |
---|---|---|
UniProt AC | P23743 | |
Protein Name | Diacylglycerol kinase alpha | |
Gene Name | DGKA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 735 | |
Subcellular Localization | ||
Protein Description | Upon cell stimulation converts the second messenger diacylglycerol into phosphatidate, initiating the resynthesis of phosphatidylinositols and attenuating protein kinase C activity.. | |
Protein Sequence | MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Phosphorylation | AKERGLISPSDFAQL CCCCCCCCHHHHHHH | 24.32 | 28122231 | |
11 | Phosphorylation | ERGLISPSDFAQLQK CCCCCCHHHHHHHHH | 38.27 | 24719451 | |
18 | Ubiquitination | SDFAQLQKYMEYSTK HHHHHHHHHHHHCCC | 55.97 | - | |
19 | Phosphorylation | DFAQLQKYMEYSTKK HHHHHHHHHHHCCCC | 5.13 | 26356563 | |
22 | Phosphorylation | QLQKYMEYSTKKVSD HHHHHHHHCCCCHHH | 12.71 | 27273156 | |
23 | Phosphorylation | LQKYMEYSTKKVSDV HHHHHHHCCCCHHHH | 22.05 | 26356563 | |
24 | Phosphorylation | QKYMEYSTKKVSDVL HHHHHHCCCCHHHHH | 33.70 | 26356563 | |
25 | Ubiquitination | KYMEYSTKKVSDVLK HHHHHCCCCHHHHHH | 45.28 | - | |
26 | Ubiquitination | YMEYSTKKVSDVLKL HHHHCCCCHHHHHHH | 47.24 | - | |
32 | Ubiquitination | KKVSDVLKLFEDGEM CCHHHHHHHHCCCHH | 51.48 | - | |
39 | Sulfoxidation | KLFEDGEMAKYVQGD HHHCCCHHHHHHCCC | 4.82 | 30846556 | |
41 (in isoform 1) | Ubiquitination | - | 44.64 | 21906983 | |
41 | Ubiquitination | FEDGEMAKYVQGDAI HCCCHHHHHHCCCCC | 44.64 | 21906983 | |
41 (in isoform 2) | Ubiquitination | - | 44.64 | 21906983 | |
50 | Phosphorylation | VQGDAIGYEGFQQFL HCCCCCCHHHHHHHH | 13.53 | 22817900 | |
133 | Phosphorylation | RNGILDSSEVDKIIL CCCCCCHHHHHHHHH | 41.11 | 29759185 | |
211 | Ubiquitination | GQHMWRPKRFPRPVY CCCCCCCCCCCCCCC | 59.08 | - | |
218 | Phosphorylation | KRFPRPVYCNLCESS CCCCCCCCCCCCCCC | 4.36 | - | |
239 | Ubiquitination | GLSCNLCKYTVHDQC CCCCCCCCCCCCCHH | 47.31 | - | |
249 | Ubiquitination | VHDQCAMKALPCEVS CCCHHHHHCCCCEEH | 28.39 | - | |
256 | Phosphorylation | KALPCEVSTYAKSRK HCCCCEEHHHCCCCC | 8.07 | 26552605 | |
257 | Phosphorylation | ALPCEVSTYAKSRKD CCCCEEHHHCCCCCC | 32.45 | 26552605 | |
258 | Phosphorylation | LPCEVSTYAKSRKDI CCCEEHHHCCCCCCC | 12.43 | 26552605 | |
260 | Ubiquitination | CEVSTYAKSRKDIGV CEEHHHCCCCCCCCC | 40.14 | - | |
263 | Ubiquitination | STYAKSRKDIGVQSH HHHCCCCCCCCCCCE | 61.87 | - | |
335 | Phosphorylation | ILPPSSIYPSVLASG CCCHHHHCHHHHHCC | 7.45 | 15773894 | |
348 | Phosphorylation | SGPDRKNSKTSQKTM CCCCCCCCCCCCHHH | 40.10 | 29978859 | |
350 | Phosphorylation | PDRKNSKTSQKTMDD CCCCCCCCCCHHHHH | 35.89 | 29978859 | |
351 | Phosphorylation | DRKNSKTSQKTMDDL CCCCCCCCCHHHHHC | 33.16 | 29978859 | |
353 | Ubiquitination | KNSKTSQKTMDDLNL CCCCCCCHHHHHCCC | 45.65 | 21906983 | |
353 (in isoform 1) | Ubiquitination | - | 45.65 | 21906983 | |
353 | Acetylation | KNSKTSQKTMDDLNL CCCCCCCHHHHHCCC | 45.65 | 23749302 | |
354 | Phosphorylation | NSKTSQKTMDDLNLS CCCCCCHHHHHCCCC | 20.42 | 29978859 | |
355 | Sulfoxidation | SKTSQKTMDDLNLST CCCCCHHHHHCCCCH | 4.93 | 21406390 | |
361 | Phosphorylation | TMDDLNLSTSEALRI HHHHCCCCHHHCCCC | 28.90 | 29978859 | |
362 | Phosphorylation | MDDLNLSTSEALRID HHHCCCCHHHCCCCC | 33.48 | 29978859 | |
363 | Phosphorylation | DDLNLSTSEALRIDP HHCCCCHHHCCCCCC | 19.93 | 29978859 | |
384 | Ubiquitination | LLVFVNPKSGGKQGQ EEEEECCCCCCCHHH | 57.43 | - | |
388 | Ubiquitination | VNPKSGGKQGQRVLW ECCCCCCCHHHEEEE | 55.57 | - | |
411 | Ubiquitination | RQVFNLLKDGPEIGL HHHHHHHHCCCCHHE | 64.90 | 21906983 | |
411 (in isoform 1) | Ubiquitination | - | 64.90 | 21906983 | |
422 | Ubiquitination | EIGLRLFKDVPDSRI CHHEEEECCCCCCEE | 63.51 | - | |
484 | Ubiquitination | YEGQNLAKILKDLEM CCCHHHHHHHHHHHH | 52.30 | 19608861 | |
484 | Acetylation | YEGQNLAKILKDLEM CCCHHHHHHHHHHHH | 52.30 | 19608861 | |
487 | Ubiquitination | QNLAKILKDLEMSKV HHHHHHHHHHHHHCC | 64.83 | 21906983 | |
487 (in isoform 1) | Ubiquitination | - | 64.83 | 21906983 | |
492 | Phosphorylation | ILKDLEMSKVVHMDR HHHHHHHHCCEEECC | 16.96 | - | |
493 (in isoform 1) | Ubiquitination | - | 47.14 | 21906983 | |
493 | Ubiquitination | LKDLEMSKVVHMDRW HHHHHHHCCEEECCC | 47.14 | 21906983 | |
501 | Phosphorylation | VVHMDRWSVEVIPQQ CEEECCCEEEECCCC | 14.86 | 29978859 | |
509 | Phosphorylation | VEVIPQQTEEKSDPV EEECCCCCCCCCCCC | 40.64 | 29978859 | |
513 | Phosphorylation | PQQTEEKSDPVPFQI CCCCCCCCCCCCEEE | 50.88 | 29978859 | |
524 | Phosphorylation | PFQIINNYFSIGVDA CEEEECCCCEECCCH | 8.33 | 29978859 | |
526 | Phosphorylation | QIINNYFSIGVDASI EEECCCCEECCCHHH | 14.20 | 29978859 | |
532 | Phosphorylation | FSIGVDASIAHRFHI CEECCCHHHHHHHHH | 18.82 | 29978859 | |
543 | Ubiquitination | RFHIMREKYPEKFNS HHHHHHHHCHHHHHH | 56.60 | - | |
544 | Phosphorylation | FHIMREKYPEKFNSR HHHHHHHCHHHHHHH | 16.33 | 25839225 | |
547 | Ubiquitination | MREKYPEKFNSRMKN HHHHCHHHHHHHHCC | 45.39 | - | |
623 | Phosphorylation | RRPHGDIYGINQALG CCCCCCCCCHHHHHC | 19.38 | 25394399 | |
632 | Phosphorylation | INQALGATAKVITDP HHHHHCCCEEEECCH | 25.80 | 26356563 | |
634 (in isoform 1) | Ubiquitination | - | 29.80 | 21906983 | |
634 | Ubiquitination | QALGATAKVITDPDI HHHCCCEEEECCHHH | 29.80 | 2190698 | |
637 | Phosphorylation | GATAKVITDPDILKT CCCEEEECCHHHHHH | 44.46 | - | |
643 | Ubiquitination | ITDPDILKTCVPDLS ECCHHHHHHHCCCCC | 39.97 | - | |
652 | Acetylation | CVPDLSDKRLEVVGL HCCCCCCCCEEEEEE | 56.35 | 25953088 | |
652 | Ubiquitination | CVPDLSDKRLEVVGL HCCCCCCCCEEEEEE | 56.35 | - | |
669 | Phosphorylation | AIEMGQIYTKLKNAG HHHHHHHHHHHHHHH | 7.02 | 29978859 | |
670 | Phosphorylation | IEMGQIYTKLKNAGR HHHHHHHHHHHHHHH | 31.37 | 29978859 | |
673 | Ubiquitination | GQIYTKLKNAGRRLA HHHHHHHHHHHHHHH | 46.43 | - | |
681 | Acetylation | NAGRRLAKCSEITFH HHHHHHHCCCEEEEE | 42.77 | 25953088 | |
681 | Ubiquitination | NAGRRLAKCSEITFH HHHHHHHCCCEEEEE | 42.77 | - | |
691 | Ubiquitination | EITFHTTKTLPMQID EEEEEECCCCCCEEC | 49.58 | - | |
714 | Ubiquitination | CTIKITHKNQMPMLM CEEEEEECCCCCEEC | 39.98 | - | |
727 | Phosphorylation | LMGPPPRSTNFFGFL ECCCCCCCCCCCCCC | 33.21 | 24719451 | |
735 | Phosphorylation | TNFFGFLS------- CCCCCCCC------- | 35.59 | 22617229 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DGKA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DGKA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ORC5_HUMAN | ORC5 | physical | 22939629 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00163 | Vitamin E |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-484, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-623, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-22, AND MASSSPECTROMETRY. |